ForntAce Medical

ForntAce Medical, founded in September 2022, possesses internationally leading independent intellectual property rights and innovative technologies. Its core team has years of in-depth experience in the field of vascular intervention, with extensive expertise in the research and development of interventional implant devices, production processes, and quality control. Addressing unmet clinical needs, the company is committed to providing patients with innovative technologies and platform-based solutions in the field of peripheral vascular intervention. Its first product, the "Spot Stent," features a self-developed coating design and replaces traditional long stents as a remedial solution following balloon angioplasty. It achieves key advantages such as more precise implantation, simpler operation for doctors, and improved vascular patency.